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Aldosterone Synthase Gene T–344C Polymorphism, 
Sodium and Blood Pressure in a Free-Living 
Population: A Community-Based Study
Kazumasa YAMAGISHI1), Takeshi TANIGAWA1), Renzhe CUI1),2), Minako TABATA1), 
Ai IKEDA3),4), Masayuki YAO1),5), Takashi SHIMAMOTO5), and Hiroyasu ISO3)
There have been few epidemiological studies on the gene-environmental interaction between the aldoste-
rone synthase gene (CYP11B2) T–344C polymorphism and sodium in relation to blood pressure in a free-
living general population. We hypothesized a priori that persons with the T allele of CYP11B2 would have
elevated blood pressure levels in response to a higher sodium intake, and thus the association between the
T–344C polymorphism and blood pressure would be more evident among persons with a high sodium
intake than among those with a low sodium intake. Study subjects were 2,823 men and women aged 30–74
in a Japanese community. We examined the associations between the T–344C polymorphism and blood
pressure levels, stratified by sodium variables estimated by 24-h urinary sodium excretion and a dietary
questionnaire. There was no significant difference in blood pressure levels among the CC, TC and TT
groups for either or both sexes. However, among persons with higher sodium excretion, mean systolic
blood pressure levels tended to be higher in those with the TC (+3.0 mmHg, p=0.06) and TT (+2.9 mmHg,
p=0.07) genotypes than in those with the CC genotype, but this tendency was not seen among those with
lower sodium excretion (–4.0 mmHg, p=0.03 for TC vs. CC; –3.0 mmHg, p=0.11 for TT vs. CC; p for inter-
action =0.006). In conclusion, we found no association between CYP11B2 and blood pressure for total sub-
jects or for persons with a higher sodium intake. However, a possible gene–blood pressure association
among persons with higher sodium intake needs to be explored further. (Hypertens Res 2007; 30: 497–502)
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Introduction
Aldosterone is synthesized by CYP11B2, a mitochondrial
cytochrome P450 enzyme. Recent biological studies suggest
that increase in aldosterone and thereby in epithelial Na+
channel (ENaC) activity may play an important role in the eti-
ology of hypertension (1). T−344C polymorphism (thymi-
dine-to-cytosine substitution at position −344 in the
regulatory region) of the CYP11B2 gene was extensively
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examined as a candidate gene of hypertension because high
levels of aldosterone increase subsequent risk of hypertension
(2). Some studies (3–6), but not all (7–12), reported that the T
allele was associated with blood pressure/hypertension, espe-
cially for low-renin hypertension (4, 5, 13), which is consid-
ered to correspond to salt-sensitive hypertension (14).
However, no community-based study has been conducted to
examine the genetic association between CYP11B2 and salt-
sensitive hypertension, probably due to the difficulty in iden-
tifying this type of hypertension in community-based sam-
ples.
Therefore, we conducted a large community-based obser-
vational study of 2,823 Japanese men and women to examine
associations of CYP11B2 polymorphism with blood pressure
levels, stratified by sodium variables. Our a priori hypothesis
was that persons with the T allele of CYP11B2 would have
elevated blood pressure in response to high sodium intake,
and thus the association between T−344C polymorphism and
blood pressure levels would be more evident among persons
with high sodium intake.
Methods
Study Population
Subjects were free-living residents of a farming community
of Kyowa (census population in 2000: n=17,145), which was
similar to that examined in our previous studies (15–17).
Briefly, we recruited subjects aged 30–74 years who had par-
ticipated in the 2001 cardiovascular risk survey (n=2,972).
Physicians explained the protocol to all participants, and
obtained written informed consent from 95% (n=2,823) of
them. The data of these 2,823 persons were used in the
present study. The study protocol was approved by the Medi-
cal Ethics Committee of the University of Tsukuba.
Population Surveys
The population surveys have been performed annually since
1981. Details of the surveys have been described elsewhere
(15–17). Well-trained blood pressure observers measured
arterial systolic blood pressure (SBP) and fifth-phase dias-
tolic blood pressure (DBP) using standard mercury sphygmo-
manometers (with a cuff 14 cm wide and 51 cm long) on the
right arm of quietly seated participants after a period of at
least 5-min rest. When the SBP was ≥140 mmHg and/or the
DBP was ≥90 mmHg, the measurement was repeated and the
average of the two readings was used in the analyses; other-
wise the single reading was used. The methods of blood pres-
sure measurement were standardized uniformly across the
surveys, and blood pressure measurement training for blood
pressure observers was provided before each annual survey.
Hypertension was defined as an SBP of ≥140 mmHg and/or
DBP of ≥90 mmHg, and/or use of antihypertensive medica-
tion. Some participants collected all urine over 24 h between
the 1982 and 2005 surveys (15). Subjects who provided urine
samples of <500 mL and/or for <20 h, or those with incom-
plete collections based on records were excluded from the
analyses. Consequently, 1,920 subjects completed the 24-h
urine collection. In addition, all participants were asked to
complete a self-administered dietary questionnaire to esti-
mate present and past sodium intake at the 2001 survey, and
99% of the subjects successfully completed the questionnaire;
the method was described in detail and validated elsewhere
(17). We used age, body mass index and alcohol intake as
confounding variables, and sodium excretion, sodium intake
as effect modifiers.
DNA Genotyping
CYP11B2 T−344C genotypes were determined by the allele-
specific primer–polymerase chain reaction (PCR) method
using Taq DNA polymerase (rTaq; Toyobo, Osaka, Japan), as
described elsewhere (18, 19). The designed allele-specific
sense primers were TxR-GTCTATTAAAAGAATCCAAGG
XTC for the T allele and FITC-TATTAAAAGAATCCA
AGGXCC for the C allele labeled at the 5′ end either with flu-
orescein isothiocyanate (FITC) or with Texas red (TxR), and
a 5′ biotin-end–labeled antisense primer (biotin-GGACTT
TATCTTATCGTGAGATGA), in which X represents an
artificial mismatch base (18).
Statistical Analyses
The analysis of covariance and χ2 test were used to compare
sex-specific age-adjusted mean values and proportions of risk
characteristics, by Tukey’s multiple comparison method. The
χ2 test was used to examine whether the genotype distribu-
tions differed from those expected from Hardy-Weinberg
equilibrium. The relation between genotype and blood pres-
sure levels was adjusted by age, sex, antihypertensive medi-
cation use (yes or no), body mass index and alcohol
consumption, and examined by the analysis of covariance,
using Dunnett’s multiple comparison method with the CC
group as a reference. Further analysis was performed strati-
fied by the medians of urinary sodium excretion and sodium
intake scores to examine whether the associations between
genotype and blood pressure levels were modified by sodium
intake. We used dummy variables for adjustment of sex and
antihypertensive medication use, and continuous variables for
other covariates. The interactions between genotype and sex,
stratified sodium variables, i.e., polymorphism (TT, TC, CC)
× sex (men or women) or polymorphism × sodium intake/
excretion (below or beyond the median values) were tested by
analysis of covariance. All statistical analyses were per-
formed using SAS version 8.02 software (SAS Institute Inc.,
Cary, USA). All probability values for statistical tests were
two-tailed; values of p<0.05 were regarded as statistically
significant, and values of 0.05≤p<0.10 as borderline signifi-
cant.
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Table 1. Means and Proportions of Characteristics According to CYP11B2 T−344C Genotype, Men and Women Aged 30–74
Years
Men Women
CC TC TT CC TC TT
Number 118 465 465 211 769 795
Age (years) 59.2 58.6 59.3 57.2 56.5 56.7
Systolic blood pressure (mmHg) 134.7 134.2 134.9 130.2 130.8 131.2
Diastolic blood pressure (mmHg) 81.3 80.6 81.0 77.2 77.0 76.8
Use of antihypertensive medication (%) 23 24 23 16 22 23*
Hypertension (%)† 45 47 49 33 40 38
Body mass index (kg/m2) 23.9 23.9 23.9 23.6 23.5 23.5
Alcohol intake (g/day) 18.8 21.2 21.6 1.7 1.7 1.5
24-h urine collection (n) 79 324 317 147 522 531
Urine sodium excretion (mmol/day) 226 202* 202* 184 181 175
Present sodium intake score completed (n) 117 461 460 208 765 791
Present sodium intake score 5.7 5.7 5.7 4.8 4.6 4.6
Past sodium intake score completed (n) 115 460 456 208 765 788
Past sodium intake score 6.8 6.8 6.9 5.8 5.9 5.9
†Hypertension was defined as systolic blood pressure of ≥140 mmHg and/or diastolic blood pressure of ≥90 mmHg and/or use of anti-
hypertensive medication. *p<0.05 for difference from CC genotype by Tukey’s multiple comparison methods.
Table 2. Blood Pressure Levels According to CYP11B2 T−344C Genotype, Men and Women Aged 30–74 Years
Men Women
CC TC TT p-value CC TC TT p-value
Total (n)† 118 465 465 211 769 795
Systolic blood pressure (mmHg) 135.0 134.2 134.9 1.00 130.5 130.8 131.1 0.77
Diastolic blood pressure (mmHg) 81.4 80.6 81.0 0.81 77.2 77.0 76.8 0.74
Stratified by urinary sodium excretion‡
Below median (n) 34 162 164 68 256 276
Systolic blood pressure (mmHg) 139.9 134.6 136.7 0.39 135.1 132.3 132.5 0.32
Diastolic blood pressure (mmHg) 82.1 80.4 81.5 0.91 78.2 77.7 76.9 0.45
Beyond median (n) 45 162 153 79 266 255
Systolic blood pressure (mmHg) 131.5 134.6 135.0 0.23 127.4 130.4 130.1 0.21
Diastolic blood pressure (mmHg) 80.4 80.6 80.2 0.98 77.6 77.3 77.3 0.95
Stratified by present sodium intake score†
Below median (n) 46 205 198 94 364 377
Systolic blood pressure (mmHg) 137.1 136.2 137.8 0.92 131.1 132.5 132.1 0.74
Diastolic blood pressure (mmHg) 82.5 81.1 82.9 0.94 76.8 77.6 77.5 0.69
Beyond median (n) 71 256 262 114 401 414
Systolic blood pressure (mmHg) 133.1 132.4 132.7 0.97 129.4 129.4 130.3 0.73
Diastolic blood pressure (mmHg) 80.5 80.3 79.6 0.66 77.4 76.5 76.3 0.34
Stratified by past sodium intake score†
Below median (n) 51 194 177 96 312 313
Systolic blood pressure (mmHg) 137.7 134.0 136.4 0.76 127.7 130.9 130.5 0.16
Diastolic blood pressure (mmHg) 82.9 80.8 82.9 1.00 75.5 77.3 76.4 0.57
Beyond median (n) 64 266 279 112 453 475
Systolic blood pressure (mmHg) 132.6 134.0 134.0 0.63 132.3 130.7 131.7 0.87
Diastolic blood pressure (mmHg) 80.2 80.5 79.7 0.87 78.5 76.8 77.2 0.25
Blood pressure was †adjusted for age, antihypertensive medication use, body mass index, alcohol consumption, and ‡further adjusted for
survey year of 24-h urine collection. Median values are 171.2 mmol/day for urinary sodium excretion in women and 195.7 mmol/day in
men, 5 for present sodium intake score in women and 6 in men, and 6 for past sodium intake score in women and 7 in men. p-values rep-
resents differences between TT and CC genotypes examined by Dunnett’s multiple comparison methods.
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Results
The sex-specific frequencies of CYP11B2 genotypes were
11.3%, 44.4%, and 44.4% for men, and 11.9%, 43.3%, and
44.8% for women, respectively. The genotype distribution
was in Hardy-Weinberg equilibrium for men (p=1.00) and
women (p=0.70). The mean age of the subjects was 59 years
for men and 57 years for women. The prevalence of hyperten-
sion was 48% for men and 38% for women, and the respec-
tive mean values of 24-h urine sodium excretions were 205
mmol and 179 mmol (data not shown in the tables).
For each sex, mean age did not vary among the CC, TC and
TT genotypes (Table 1). Neither mean SBP nor mean DBP
was significantly different among the three genotypes. How-
ever, the use of antihypertensive medication was more preva-
lent among women with the TT genotype than those with the
CC genotype. Urinary sodium excretion was lower among
men with the TC and TT genotypes than those with the CC
genotype. The other variables were similar among the geno-
types.
The mean values of blood pressure levels adjusted for age,
antihypertensive medication use, body mass index and alco-
hol consumption are shown for each CYP11B2 genotype
(Table 2). Overall, there was no significant difference in
blood pressure levels. Also, we found no association between
T−344C polymorphism and blood pressure levels when strat-
ified by urinary sodium excretion, present sodium intake, and
past sodium intake score (Table 2). However, when men and
women were combined (Fig. 1), the SBP levels among per-
sons with the higher urinary sodium excretion tended to be
positively associated with the T allele: 129.0 mmHg for the
Fig. 1. Mean systolic and diastolic blood pressure levels and 95% confidence intervals according to CYP11B2 T−344C geno-
types by sodium excretion. The median values of urinary sodium excretion were 195.7 mmol/day for men and 171.2 mmol/day for
women.
p 60.0= 
p 70.0= 
p 30.0= 
p 11.0= 
p 00.1= 
p 59.0= 
p 16.0= 
p 94.0= 
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CC genotype, 132.0 mmHg for the TC genotype (p=0.06 vs.
the CC genotype), and 131.9 mmHg for the TT genotype
(p=0.07), but not among those with lower sodium excretion:
137.1 mmHg for the CC genotype, 133.1 mmHg for the TC
genotype (p=0.03) and 134.1 mmHg for the TT genotype
(p=0.11). The interaction between urinary sodium excretion
and genotype in relation to SBP was statistically significant
(p=0.006).
The associations between CYP11B2 genotypes and blood
pressure levels were not altered materially when subjects
were restricted to those without antihypertensive medication
(n=1,112). For example, the SBP levels in persons with
higher sodium excretion were 126.0 mmHg, 129.3 mmHg
(p=0.07) and 129.2 mmHg (p=0.08), respectively, and those
in persons with lower sodium excretion were 134.5 mmHg,
130.3 mmHg (p=0.05) and 131.1 mmHg (p=0.13), respec-
tively.
Discussion
We found no significant difference in blood pressure levels
between the CC, TC and TT genotypes for either sex in the
total subjects. The lack of association is not surprising,
because this finding was consistent with the results of previ-
ous studies (7–12). However, a positive association was sug-
gested between the CYP11B2 TT genotype and SBP levels
among persons with higher sodium excretion, but not for
those with lower sodium excretion.
The results from previous studies examining the associa-
tion between the T−344C polymorphism and blood pressure/
hypertension have been inconsistent. A Japanese population-
based study (10) showed no association between the T−344C
polymorphism and 24-h ambulatory SBP or DBP, but sub-
jects with the CC genotype showed a greater reduction in noc-
turnal SBP levels than those with the TC or TT genotypes.
However, several population-based studies from Japanese
(9), Indian (11), and black and white English (7) showed no
association between the T−344C polymorphism and blood
pressure/hypertension, whereas other population-based stud-
ies from Italian (5, 12) and multi-ethnic populations (6)
showed a positive association with SBP or both SBP and
DBP.
Our a priori hypothesis was based on the previous reports
that showed a positive association between the T−344C poly-
morphism and low-renin hypertension (4, 5), which is consid-
ered to correspond to salt-sensitive hypertension (13). Since
Japanese populations have a higher sodium intake than West-
ern countries (20), we assumed that the high sodium intake
may have helped to make the CYP11B2 gene–blood pressure
association more evident. The present study supported our
hypothesis. Previous studies (21–23), however, showed no
association between the T−344C polymorphism and salt sen-
sitivity among relatively young subjects (mean age of 25 to
47 years).
Although our a priori hypothesis was not clearly supported,
the present study has several strengths. The present study was
the first community-based observational study of a gene–
sodium intake interaction on blood pressure with a large sam-
ple size, which allowed us to conduct stratified analyses. Sec-
ond, mean sodium intake was higher in the present Japanese
subjects than in Western countries, which may have consti-
tuted an advantage for examining the gene–sodium intake
interaction.
The present study has several limitations. First, we used
only a single blood pressure measurement in the analyses, and
thus measurement variability may have weakened the genetic
associations. However, since the number of the study subjects
was large, we attained enough statistical power to detect
gene–blood pressure associations. Second, approximately
20% of subjects used antihypertensive medication, which
may have obscured the genetic effect of blood pressure levels.
However, this possibility is unlikely, since the exclusion of
persons on antihypertensive medication did not alter the
genetic associations materially. Last, the variation of sodium
excretion by one 24-h urine sample may be large, and mis-
classification between the low and high sodium excretion
groups is inevitable. However, since the study had a large
sample size, the impact of misclassification across the strati-
fication was probably small. In the present study, 66% of per-
sons remained in the same group of higher or lower sodium
intake after 1–5 years re-collection of urinary sodium excre-
tion for the sub-sample.
In conclusion, the CYP11B2 T allele was not associated
with high blood pressure levels for total subjects or for per-
sons with a higher sodium intake. However, a possible gene–
blood pressure association among persons with a higher
sodium intake needs to be explored in a future study.
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